이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Lifestyle Intervention for Pakistani Women in Oslo (InnvaDiab)

2014년 6월 24일 업데이트: Gerd Holmboe-Ottesen, University of Oslo

Evaluation of a Lifestyle Intervention to Prevent Type 2 Diabetes/Metabolic Syndrome Among Pakistani Immigrants - Focusing on Changes in Diet and Physical Activity

Immigrants from South Asia in Norway have a high prevalence of type 2 diabetes and conditions related to the metabolic syndrome. It has been documented that these conditions may be prevented by changes in lifestyle. No previous intervention studies on immigrants with focus on diet and physical activity have been carried out in Norway. This project concerns a randomized controlled trial with intervention to change diet and physical activity in 200 high risk female Pakistani immigrants living in Oslo. The intervention will be evaluated both in terms of outcome and process.

연구 개요

상세 설명

Objectives:

  1. To evaluate the health effects of systematic dietary education and counselling and physical training in a group of Pakistani women with high risk of type 2 diabetes.
  2. To evaluate the intervention process in order to identify the most effective methods of intervention in regard to diet and physical activity for immigrant women of Pakistani origin.

Background: Immigrants from South Asia have a high prevalence of type 2 diabetes, which may be prevented by intensive on physical activity and diet. This application concerns intervention with diet and physical activity in female (ongoing study) and male (extended study) Pakistani immigrants living in Oslo to reduce their risk for these diseases.

Intervention design: The subjects will be 200 women randomized into an intervention group and a control group (100 in each). The women are being recruited from a township in Oslo with a high proportion of immigrants by using a network approach. Inclusion criteria is based on a risk score developed by Ramachandran et al for Asian Indians, entailing age, Body Mass Index, waist circumference, family history of diabetes and sedentary physical activity.

The intervention will include a combination of individual counselling and group sessions. The intervention group will be divided into subgroups of 10-12 subjects. Each subgroup will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a cultural adapted exercise program of low intensity twice a week. This includes indoor activities (exercise with music) and outdoor activities (walking groups).

Evaluation: The main end point of the intervention will be the fasting and 2-h plasma glucose value after an oral glucose tolerance test (OGTT). This will be measured at baseline and after 6 months of intervention.

Secondary end-points will be Serum lipid profile (e.g. triglycerides, High-Density Lipoprotein-cholesterol) ; HbA1c ; C-peptide ; serum insulin; serum albumin; body weight; waist and hip circumference; maximum heart rate on treadmill test; self-reported level of intensity, duration and frequency of physical activity; self-reported level of "Stages of change" in regard to motivation and behavioural change; self- reported subjective health complaints; self-reported coping strategies; self-reported sleeping habits.

Dietary information will be collected by 2 x 48 hours dietary recalls. The intake of energy and nutrients will be calculated from the recalls, as well as the intake of food groups.The diet will also be evaluated by a culturally adapted food frequency questionnaire including 20 food groups (with portion sizes). In addition, the use of cooking oils will be registered by questions about the type and quantity oil used per time unit in the household. Additionally, information on knowledge and perceptions on diet and health before and after the intervention will be registered.

Physical activity will be registered using an advanced continuous body monitor, SenseWear Armband yielding information on total energy expenditure, level of intensity, duration and frequency of physical activity, duration of lying down, duration of sleeping, and sleeping quality.

The completion of the questionnaires will take the form of an interview by Urdu speaking staff.

연구 유형

중재적

등록 (실제)

198

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Holmlia, Oslo
      • Oslo, Holmlia, Oslo, 노르웨이, 1255
        • Primary Health Care Health Center

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

25년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

여성

설명

Inclusion Criteria:

  • Risk score developed by Ramachandran et al for Asian Indians:

    • BMI, waist circumference, family history of diabetes and sedentary physical activity

Exclusion Criteria:

  • Type 1 diabetes.
  • Positive auto antibodies.
  • Diagnosis of type 2 diabetes more than 6 months.
  • Medication for type 2 diabetes.
  • Pregnancy at intervention start.
  • Suffering from heart attack or stroke the last 3 months.
  • Already participating in organised physical exercise.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 방지
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Intervention
The intervention group was divided into nine subgroups of ten to twelve women who were offered six educational sessions, each lasting 2 h, during a 7 +- 1-month period. The main focus was on the physiological importance of blood glucose and its regulation by diet and physical activity, and on knowledge about the Pakistani lifestyle in Pakistan and Norway
The intervention will include a combination of individual counselling group sessions. The intervention groups will be divided into subgroups of 10-12 subjects. Each group will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a culturally adapted exercise program of low intensity twice a week.
간섭 없음: Control
One lesson recieved after post-test

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
기간
The Fasting Plasma Glucose Value, Baseline
기간: baseline
baseline
Plasma Glucose 2 h After Oral Glucose Tolerance Test, Baseline
기간: baseline
baseline
The Fasting Plasma Glucose, Post-test
기간: post-test
post-test
Plasma Glucose, 2-h, Post-test
기간: post-test
post-test

2차 결과 측정

결과 측정
기간
HbA1c, Baseline
기간: baseline
baseline
C-peptide, 0-h, Baseline
기간: baseline
baseline
C-peptid, 2-h, Baseline
기간: baseline
baseline
Insulin, 0-h, Baseline
기간: baseline
baseline
Insulin, 2-h, Baseline
기간: baseline
baseline
High-Density Lipoprotein Cholesterol, Baseline
기간: baseline
baseline
Triglycerides, Baseline
기간: baseline
baseline
Systolic Blood Pressure, Baseline
기간: baseline
baseline
Diastolic Blood Pressure, Baseline
기간: baseline
baseline
Waist Circumference, Baseline
기간: baseline
baseline
Body Mass Index, Baseline
기간: baseline
baseline
Intake of Vegetables, Fruit and Fruit Juice, Baseline
기간: baseline
baseline
Intake of Soft Drinks With Added Sugar, Baseline
기간: baseline
baseline
Intake of Red Meat, Baseline
기간: baseline
baseline
Intake of Poultry, Baseline
기간: baseline
baseline
Intake of Fish, Baseline
기간: baseline
baseline
HbA1C, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
C-peptid, 0-h, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
C-peptid, 2-h, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Insulin, 0-h, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Insulin, 2-h, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
High-Density Lipoprotein Cholesterol, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Triglycerides, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Systolic Blood Pressure, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Diastolic Blood Pressure, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Waist Circumference
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Body Mass Index, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Vegetables, Fruit and Fruit Juice, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Soft Drinks With Added Sugar, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Red Meat, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Poultry, Post-test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Fish, Post Test
기간: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Gerd Holmboe-Ottesen, Dr. Philos., University of Oslo

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2006년 4월 1일

기본 완료 (실제)

2008년 9월 1일

연구 완료 (실제)

2008년 9월 1일

연구 등록 날짜

최초 제출

2007년 1월 19일

QC 기준을 충족하는 최초 제출

2007년 1월 19일

처음 게시됨 (추정)

2007년 1월 22일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2014년 7월 21일

QC 기준을 충족하는 마지막 업데이트 제출

2014년 6월 24일

마지막으로 확인됨

2014년 4월 1일

추가 정보

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다